Literature DB >> 9696434

Magnesium in dialysis patients: serum levels and clinical implications.

J F Navarro-González1.   

Abstract

Magnesium is the fourth most abundant cation in the body and is involved in many cell functions. Serum magnesium concentration is maintained within a narrow range by the kidney and digestive tract. Patients with chronic renal failure have an increased body magnesium content. In subjects on hemodialysis and peritoneal dialysis the serum magnesium concentration parallels the dialysate magnesium level. Hypermagnesemia in these patients is frequent, usually mild (serum magnesium lower than 1.5 mmol/l) and asymptomatic, but severe and symptomatic hypermagnesemia can be induced by exogenous magnesium administration. The last section of this review briefly summarizes the clinical implications of hypermagnesemia in dialysis population with special interest on the influence of magnesium on bone disease and parathyroid gland function.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9696434

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  9 in total

1.  The effect of different dialysate magnesium concentrations on QTc dispersion in hemodialysis patients.

Authors:  Farsad Afshinnia; Hardik Doshi; Panduranga S Rao
Journal:  Ren Fail       Date:  2012-02-02       Impact factor: 2.606

2.  A case of cardiopulmonary arrest caused by laxatives-induced hypermagnesemia in a patient with anorexia nervosa and chronic renal failure.

Authors:  Hiroomi Tatsumi; Yoshiki Masuda; Hitoshi Imaizumi; Hiromitsu Kuroda; Shin-ichiro Yoshida; Ryoko Kyan; Kyoko Goto; Yasufumi Asai
Journal:  J Anesth       Date:  2011-09-09       Impact factor: 2.078

3.  Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis.

Authors:  Faruk Turgut; Mehmet Kanbay; Melike Rusen Metin; Ebru Uz; Ali Akcay; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2008-06-21       Impact factor: 2.370

Review 4.  Dialysate Potassium, Dialysate Magnesium, and Hemodialysis Risk.

Authors:  Patrick H Pun; John P Middleton
Journal:  J Am Soc Nephrol       Date:  2017-10-09       Impact factor: 10.121

5.  Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability.

Authors:  Angel L M de Francisco; Michael Leidig; Adrian C Covic; Markus Ketteler; Ewa Benedyk-Lorens; Gabriel M Mircescu; Caecilia Scholz; Pedro Ponce; Jutta Passlick-Deetjen
Journal:  Nephrol Dial Transplant       Date:  2010-06-07       Impact factor: 5.992

6.  Platelet counts and mean platelet volume in association with serum magnesium in maintenance hemodialysis patients.

Authors:  Mahmoud Rafieian-Kopaie; Hamid Nasri
Journal:  J Renal Inj Prev       Date:  2012-01-01

7.  A case of tetanus treated with Kampo medicines such as Kakkonto and Shakuyakukanzoto.

Authors:  Hajime Nakae; Yuri Saito; Manabu Okuyama; Toshiko Igarashi
Journal:  Acute Med Surg       Date:  2016-12-01

8.  Why are serum magnesium levels lower in Saudi dialysis patients?

Authors:  Ahmed H Mitwalli
Journal:  J Taibah Univ Med Sci       Date:  2016-10-15

9.  Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.

Authors:  Min Seok Cho; Kyun Sang Lee; Youn Kyoung Lee; Seong Kwon Ma; Jeong Hee Ko; Soo Wan Kim; Nam Ho Kim; Ki Chul Choi
Journal:  Korean J Intern Med       Date:  2002-06       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.